Changjiang Yu

1.4k total citations
65 papers, 998 citations indexed

About

Changjiang Yu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changjiang Yu has authored 65 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changjiang Yu's work include Aortic Disease and Treatment Approaches (15 papers), Aortic aneurysm repair treatments (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Changjiang Yu is often cited by papers focused on Aortic Disease and Treatment Approaches (15 papers), Aortic aneurysm repair treatments (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Changjiang Yu collaborates with scholars based in China, United States and Canada. Changjiang Yu's co-authors include Tucheng Sun, Nanbo Liu, Shuoji Zhu, Mingyi Zhao, Ping Zhu, Bin‐Lin Song, Rui Guo, Ming‐Hui Zou, Jian Zhuang and Zhi‐Ren Zhang and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Changjiang Yu

53 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Changjiang Yu China	19	309	189	175	147	138	65	998
Finosh G. Thankam United States	23	296 1.0×	273 1.4×	574 3.3×	179 1.2×	71 0.5×	83	1.4k
Yi Liang China	18	382 1.2×	126 0.7×	114 0.7×	85 0.6×	40 0.3×	55	935
Katherine Athayde Teixeira de Carvalho Brazil	18	313 1.0×	263 1.4×	463 2.6×	126 0.9×	94 0.7×	85	1.1k
Junwang Xu United States	22	407 1.3×	171 0.9×	117 0.7×	96 0.7×	68 0.5×	49	1.5k
David Dolivo United States	14	257 0.8×	200 1.1×	227 1.3×	40 0.3×	49 0.4×	38	832
Hanna Hlawaty France	20	318 1.0×	210 1.1×	160 0.9×	59 0.4×	73 0.5×	33	1.0k
Zhen Tan China	19	330 1.1×	90 0.5×	157 0.9×	130 0.9×	67 0.5×	48	993
Emmett Pinney United States	10	600 1.9×	159 0.8×	142 0.8×	66 0.4×	58 0.4×	12	1.1k
Ileana Ruxandra Botusan Sweden	16	453 1.5×	125 0.7×	182 1.0×	43 0.3×	65 0.5×	21	1.3k

Countries citing papers authored by Changjiang Yu

Since Specialization

Citations

This map shows the geographic impact of Changjiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjiang Yu more than expected).

Fields of papers citing papers by Changjiang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjiang Yu. The network helps show where Changjiang Yu may publish in the future.

Co-authorship network of co-authors of Changjiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Changjiang Yu. A scholar is included among the top collaborators of Changjiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjiang Yu. Changjiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Xinyu, Mei Zhang, Qi Qin, et al.. (2025). KAT7 contributes to ponatinib-induced hypertension by promoting endothelial senescence and inflammatory responses through activating NF-κB signaling pathway. Journal of Hypertension. 43(5). 827–840. 1 indexed citations

Yu, Changjiang, Liu Ouyang, Junqing An, et al.. (2025). Smooth muscle cell (SMC)-Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death. Biochemistry and Biophysics Reports. 44. 102298–102298.

Yu, Changjiang, et al.. (2025). High‐Efficiency Energy Storage: High Entropy Materials Design and Interface Regulation Mechanism. Advanced Functional Materials. 36(12). 1 indexed citations

Yu, Changjiang, et al.. (2024). The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation. PeerJ. 12. e18476–e18476.

Liu, Wenfeng, Xiao-Xue Li, Changjiang Yu, et al.. (2024). Preparation and catalytic degradation performance of nanoporous FeSiB amorphous alloy. Journal of Physics and Chemistry of Solids. 199. 112527–112527. 2 indexed citations

Sun, Tucheng, et al.. (2024). Thoracoabdominal aortic replacement in a 6-year-old boy with Loeys-Dietz syndrome. Journal of Cardiothoracic Surgery. 19(1). 530–530.

Wu, Yang, et al.. (2023). Human ApoE2 Endows Stronger Contractility in Rat Cardiomyocytes Enhancing Heart Function. Cells. 12(3). 347–347.

Yang, Jue, et al.. (2023). Human aortic smooth muscle cell regulation by METTL3 via upregulation of m6A NOTCH1 modification and inhibition of NOTCH1. Annals of Translational Medicine. 11(10). 350–350. 7 indexed citations

Liu, Nanbo, Shuoji Zhu, Mingyi Zhao, et al.. (2022). Construction of multifunctional hydrogel with metal-polyphenol capsules for infected full-thickness skin wound healing. Bioactive Materials. 24. 69–80. 89 indexed citations

10.

Ouyang, Liu, Changjiang Yu, Zhi Xie, et al.. (2022). Indoleamine 2,3-Dioxygenase 1 Deletion–Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification. Circulation. 145(24). 1784–1798. 48 indexed citations

11.

Yu, Changjiang, Longlong Zhang, Fuli Wang, et al.. (2021). PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt. Biochemical and Biophysical Research Communications. 571. 66–73. 10 indexed citations

12.

Wang, Qiushi, Liang Chen, Shuai Jiang, et al.. (2021). NaHS or Lovastatin Attenuates Cyclosporine A–Induced Hypertension in Rats by Inhibiting Epithelial Sodium Channels. Frontiers in Pharmacology. 12. 665111–665111. 6 indexed citations

13.

Yang, Jue, Xin Li, Zerui Chen, et al.. (2021). Case Report: Intraoperative Open-Heart Coronary Angiography in Acute Type A Aortic Dissection. Frontiers in Cardiovascular Medicine. 8. 731581–731581. 1 indexed citations

14.

Ramprasath, Tharmarajan, Young‐Min Han, Donghong Zhang, Changjiang Yu, & Ming‐Hui Zou. (2021). Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases. Frontiers in Immunology. 12. 731701–731701. 30 indexed citations

15.

Yu, Changjiang, et al.. (2021). The Self-Inflicted Multiple Organs Injury with Nail Gun. The Heart Surgery Forum. 24(6). E1049–E1051.

16.

Wang, Zirui, Yuxia Li, Changjiang Yu, et al.. (2017). Dietary salt blunts vasodilation by stimulating epithelial sodium channels in endothelial cells from salt‐sensitive Dahl rats. British Journal of Pharmacology. 175(8). 1305–1317. 27 indexed citations

17.

Gao, Ling, Pi‐Xiao Wang, Yaxing Zhang, et al.. (2016). Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis. Journal of Hepatology. 65(1). 125–136. 41 indexed citations

18.

Liu, Huibin, Yuanfeng Gong, Changjiang Yu, et al.. (2013). Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent. SHILAP Revista de lepidopterología. 1(1). 9–9. 15 indexed citations

19.

Vandegraaff, Nick, David I. Rhodes, E. D. Jones, et al.. (2010). Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. Bioorganic & Medicinal Chemistry Letters. 20(17). 5013–5018. 16 indexed citations

20.

Yu, Changjiang. (2009). Discussion on sustainable development of the international seafarer providing market under current situation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact